| 1 |
Zhao M, Zhao Q, Guan Z, Liu Q, Zhou H, Huang Q, Huo B. Effect of Panax ginseng and Fructus Mume on Intestinal Barrier and Gut Microbiota in Rats with Diarrhea. J Med Food 2023;26:165-75. [PMID: 36827387 DOI: 10.1089/jmf.2022.K.0069] [Reference Citation Analysis]
|
| 2 |
Ma Y, Wu L, Niu L. Screening of Biomarkers and Quality Control of Shaoyao Gancao Decoction Using UPLC-MS/MS Combined with Network Pharmacology and Molecular Docking Technology. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-24. [DOI: 10.1155/2022/2442681] [Reference Citation Analysis]
|
| 3 |
Liu S, Zhang Y, Yang F, Gu J, Zhang R, Kuang Y, Mai W, Zheng C, Yu Y, Lu R, Zeng L, Cao H, Long Y. Modified Cangfu Daotan decoction ameliorates polycystic ovary syndrome with insulin resistance via NF-κB/LCN-2 signaling pathway in inflammatory microenvironment. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.975724] [Reference Citation Analysis]
|
| 4 |
Chen C, Livneh H, Chen W, Wang Y, Lu M, Yeh C, Yen C, Tsai T. The Prescription of Chinese Herbal Medicine and Risk of Endometriosis in Women with Rheumatoid Arthritis: A Population-Based Cohort Study. IJWH 2022;Volume 14:1603-1612. [DOI: 10.2147/ijwh.s386134] [Reference Citation Analysis]
|
| 5 |
Liu M, Yan J, Wu Y, Zhu H, Huang Y, Wu K. The impact of herbal medicine in regulating intestinal flora on female reproductive disorders. Front Pharmacol 2022;13:1026141. [DOI: 10.3389/fphar.2022.1026141] [Reference Citation Analysis]
|
| 6 |
Zhang J, Xin X, Zhang H, Zhu Y, Ye Y, Li D. The Efficacy of Chinese Herbal Medicine in Animal Models of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-14. [DOI: 10.1155/2022/4892215] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Wang Y, Xiao H, Liu Y, Tong Q, Yu Y, Qi B, Bu X, Pan T, Xing Y. Effects of Bu Shen Hua Zhuo formula on the LPS/TLR4 pathway and gut microbiota in rats with letrozole-induced polycystic ovary syndrome. Front Endocrinol 2022;13:891297. [DOI: 10.3389/fendo.2022.891297] [Reference Citation Analysis]
|
| 8 |
Sun B, Pan Z, Kuang H, Feng X, Hou L, Xu F, Song F, Sun M. TLR4/NF-κB Signaling Contributes to the Inflammation in Ovary and Inguinal Fats of Polycystic Ovary Syndrome.. [DOI: 10.1101/2022.07.14.500077] [Reference Citation Analysis]
|
| 9 |
Li Z, Liu Y, Liu H, Wu Z, Xu C, Zhang F. Liquiritin ameliorates metabolic and endocrine alterations in a mouse model of polycystic ovary syndrome. Reproductive and Developmental Medicine 2022;6:104-112. [DOI: 10.1097/rd9.0000000000000025] [Reference Citation Analysis]
|
| 10 |
Chen Y, Lu R, Wang Y, Gan P. Shaoyao Gancao Decoction Ameliorates Paclitaxel-Induced Peripheral Neuropathy via Suppressing TRPV1 and TLR4 Signaling Expression in Rats. DDDT 2022;Volume 16:2067-2081. [DOI: 10.2147/dddt.s357638] [Reference Citation Analysis]
|
| 11 |
Zhao H, Chen R, Zheng D, Xiong F, Jia F, Liu J, Zhang L, Zhang N, Zhu S, Liu Y, Zhao L, Liu X. Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota. Front Cell Infect Microbiol 2022;12:854796. [DOI: 10.3389/fcimb.2022.854796] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Refaie MMM, El-Hussieny M, Shehata S. TLR4/NF-κB/TNFα and cAMP/SIRT1 signaling cascade involved in mediating the dose-dependent effect of cilostazol in ovarian ischemia reperfusion-induced injury. Immunopharmacol Immunotoxicol 2022;:1-9. [PMID: 35209787 DOI: 10.1080/08923973.2022.2043901] [Reference Citation Analysis]
|
| 13 |
Gu Y, Zhou G, Zhou F, Li Y, Wu Q, He H, Zhang Y, Ma C, Ding J, Hua K. Gut and Vaginal Microbiomes in PCOS: Implications for Women’s Health. Front Endocrinol 2022;13:808508. [DOI: 10.3389/fendo.2022.808508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
